Chemist Warehouse, an Australian pharmacy chain, is set to expand its presence in New Zealand by opening an additional 26 stores, following significant sales growth. This announcement was made by its parent company, Sigma Healthcare, as part of their financial results for the fiscal year ending June 30, 2026. While specific financial details regarding the New Zealand operations were not disclosed, it was noted that Chemist Warehouse’s international segment, which includes 98 stores globally, generated a 23.3% increase in sales to A$1.6 billion (approximately $1.93 billion) year-on-year, with a like-for-like sales growth of 12.2%. Currently, 75 of these stores are located in New Zealand, with the remainder spread across Ireland, China, and the UAE.
Why It Matters
The expansion of Chemist Warehouse in New Zealand underscores the company’s successful growth strategy and the increasing demand for pharmacy services in the region. With a significant year-on-year sales increase, the company is capitalizing on the health and wellness market, which has been expanding globally. Historically, Chemist Warehouse has positioned itself as a cost-effective retailer in the pharmacy sector, which may contribute to its growing store network. This expansion could also reflect broader trends in retail pharmacy, where increased consumer spending on health products is evident, indicating a potentially lucrative market for pharmacy chains.
Want More Context? 🔎